Affiliation:
1. Department of Physical and Rehabilitation Medicine Hacettepe University Medical School Ankara Turkey
2. Department of Physical Medicine and Rehabilitation Mubarak Alkabeer Hospital Jabriya Kuwait
3. Department of Physical Medicine and Rehabilitation Mohammed VI University Hospital of Oujda Oujda Morocco
4. Faculty of Medicine and Pharmacy of Oujda Mohammed First University of Oujda Oujda Morocco
Abstract
The management of chronic migraine (CM) underwent a significant shift with the introduction of onabotulinumtoxin A (BoNT‐A) injections following the landmark PREEMPT trial in 2010. Despite its efficacy, the existing injection protocol lacks precision, prompting a call for revision in light of modern ultrasound (US)‐guided techniques. This article highlights the potential of US‐guided injections to enhance accuracy, safety, and efficacy in CM treatment. By providing real‐time visualization and addressing anatomical variations, US guidance offers a promising avenue for optimizing BoNT‐A delivery, minimizing adverse effects, and ensuring therapeutic success.